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NEUROD1 is a tissue-specific basic helix loop helix 
(bHLH) transcription factor that plays an important role in 
the development and maintenance of neuronal elements [1] 
and the endocrine pancreas [2, 3]. It also plays a key role in 
maintaining normal glucose homeostasis [2, 3].
Most of our knowledge on the function of NEUROD1 
comes from animal experiments. NEUROD1 is expressed 
in differentiated neurons of frogs and mice [4]. It has been 
shown that NEUROD1 can transform ectodermal cells into 
differentiated neurons in Xenopus [4]. In addition, NEUROD1 
is expressed in the fully differentiated neurons of the adult 
Xenopus brain structures, including the hippocampus, 
cerebellum, and olfactory bulbs [4]. NEUROD1 null mutant 
mice kept alive by either a transgene encoding the mouse 
NEUROD1 gene under the insulin promoter [5] or by crossing 
the null mutation into a different genetic background [6] 
showed concordant neuronal phenotypes, including ataxic 
gate, impaired balance, circling, impaired cerebellar func-
tion [5-7], and epilepsy [6]. Abnormal hearing and vision are 
caused by sensory defects of the inner ear and neural retina 
[7-9].
Morrow et al. [9] investigated the expression of 
NEUROD1 in rat and mouse retinas. Despite the two different 
methods, NEUROD1 was found to be expressed mainly in 
undifferentiated retinal cells, developing amacrine interneu-
rons, and photoreceptors. Moreover, its expression could be 
observed in terminally differentiated photoreceptors in the 
mature retina. The suppression of NEUROD1 gene expres-
sion leads to severe impairment of photoreceptor development 
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Purpose: NEUROD1 is a tissue-specific basic helix loop helix (bHLH) protein involved in the development and main-
tenance of the endocrine pancreas and neuronal elements. Loss of NEUROD1 causes ataxia, cerebellar hypoplasia, 
sensorineural deafness, and severe retinal dystrophy in mice. Heterozygous loss-of-function mutations in NEUROD1 
have previously been described as a cause of maturity-onset diabetes of the young (MODY) and late-onset diabetes. 
To date, homozygous loss-of-function NEUROD1 mutations have only been detected in two patients. Both mutations 
caused permanent neonatal diabetes and severe neurologic defects, including visual impairment. However, a detailed 
ophthalmological phenotype of this novel syndrome has not yet been reported. Our aim was to characterize the ophthal-
mological phenotype associated with the previously reported homozygous c.427_428CT mutation in the NEUROD1 gene.
Methods: The female patient was investigated on multiple occasions between 2009 (age 14) and 2014 (age 19), including 
visual acuity testing, automated perimetry, funduscopy, anterior-segment imaging, optical coherence tomography of the 
posterior pole, standard full-field electroretinography, and fundus-autofluorescence imaging.
Results: The patient had nyctalopia, blurry vision, and visual field constriction from early childhood. Her best corrected 
visual acuity ranged between 20/25 and 15/25 during the investigation period. Perimetry showed concentric constriction 
of the visual field, sparing only the central 30 degrees in both eyes. The anterior segment did not show any morphological 
changes. Optical coherence tomography revealed total absence of the photoreceptor layer of the retina outside the fovea, 
where a discoid remnant of cone photoreceptors could be detected. Neither setting of the standard full-field electroreti-
nography could detect any electrical response from the retina. Color fundus photos presented peripheral chorioretinal 
atrophy and central RPE mottling. A hyperreflective parafoveal ring was detected on fundus autofluorescent photos, a 
characteristic sign of hereditary retinal dystrophies.
Conclusions: To the best of our knowledge, this is the first report on the ophthalmological phenotype associating with 
a homozygous NEUROD1 null mutation in humans. Our results indicate that the loss of NEUROD1 has similar func-
tional and anatomic consequences in the human retina as those described in mice. The present description can help the 
diagnosis of future cases and provide clues on the rate of disease progression.
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in chick retinas, indicating its importance in the formation of 
photoreceptors [10].
To define the role of NEUROD1 in the retina, Ocho-
cinska et al. [11] used NEUROD1 conditional knockout mice 
(cKO). They observed that two-month-old NEUROD1 cKO 
retinas underwent dramatic changes, including reductions in 
rod- and cone-driven electroretinograms and disorganized 
outer segments. Furthermore, photoreceptors totally disap-
peared in later ages. Microarray analysis identified two 
downregulated genes: Aipl1, which is necessary to prevent 
retinal degeneration, and Ankrd33, which is expressed in the 
outer segment of the retina. It is suggested that NEUROD1 
is involved in receptor homeostasis through these genes [11]. 
Although NEUROD1 is expressed in all three layers of the 
mouse retina, degeneration only affects the photorecep-
tors [12]. In contrast, Acharya et al. [13] demonstrated that 
NEUROD1 transcripts and NEUROD1 immunoreactivity are 
predominantly localized to the outer nuclear layer in the adult 
human retina.
Heterozygous loss-of-function mutations in the 
NEUROD1 gene have been described in the background 
of maturity-onset diabetes of the young (MODY) and late-
onset diabetes [14-17]. There are only two unrelated patients 
with two different homozygous loss-of-function NEUROD1 
mutations described so far. Both single base pair duplication 
(c.364dupG) and two base pair CT deletion (c.427_428del) 
result in a frameshift and a premature truncation of the 
C-terminus of the expressed protein (p.Asp122Glyfs*12 and 
p.Leu143Alafs*55, respectively), leading to mutated proteins 
completely lacking the transactivation domain [18]. These 
two probands were diagnosed with permanent neonatal 
diabetes (PNDM) and had similar neurologic abnormalities, 
including cerebellar hypoplasia, developmental delay, and 
visual and hearing impairment [18]. Interestingly, the rescued 
NEUROD1-null mice [5-9] and the two NEUROD1-deficient 
patients showed similar disease manifestations except 
epilepsy, which was only seen in the mice [6]. However, no 
further information on the ophthalmic phenotype and its 
functional consequences was provided in that article.
In the present study, we provide detailed ophthalmo-
logical characterization of the patient with homozygous 
c.427_428delCT NEUROD1 mutation. To the best of our 
knowledge, this is the first description of the ophthalmo-
logical phenotype caused by a homozygous NEUROD1 null 
mutation.
METHODS
Color fundus photographs were taken with a Zeiss FF450+IR 
fundus camera (Carl Zeiss AG, Jena, Germany) mounted with 
a ZK-5 color sensor (Allied Vision Technologies GmbH, 
Stadtroda, Germany) and operated with Zeiss Visupack 4.4 
software. Optical coherence tomography and confocal-scan-
ning laser fundus autofluorescence imaging were performed 
with SpectralisOCT (Heidelberg Engineering, Heidelberg, 
Germany). Electroretinography was executed with Ganzfeld 
Q400 equipment (Roland Consult GmbH, Brandenburg, 
Germany) using standard ISCEV parameters [19]. The visual 
field was investigated with an Octopus 900 automated static 
perimeter, using its standard white/white full-size visual field 
program (Haag Streit AG, Koenitz, Switzerland). All of the 
procedures applied in this study strictly adhered to the tenets 
of the Declaration of Helsinki.
RESULTS
We annually examined a female patient having neonatal 
diabetes caused by a homozygous loss-of-function mutation 
in the NEUROD1 gene between 2009 (age 14) and 2014 (age 
19). The patient had normal blood glucose control using 
insulin supplementation. The patient complained about slowly 
progressive blurry vision, constriction of the visual field, and 
difficulties seeing at night or in dim light, beginning in early 
childhood. Her best corrected visual acuity showed a slow 
decrease during the exam period, ranging from 20/25 to 
15/25. Refractive error did not show any changes between the 
examinations: -7.5D spherical with +3.0D cylindrical correc-
tion in both eyes. Automated full-size visual field perimetry 
showed concentric constriction of the visual field, sparing the 
central 30 degrees in both eyes, in 2013. The patient showed 
normal color recognition on pseudoisochromatic charts.
Scheimpflug imaging of the anterior segment showed 
regular oblique corneal astigmatism. Corneal thickness was 
near normal, with a central corneal thickness of 600 µm. 
No signs of Keratoconus could be detected with Scheimp-
flug imaging using the Belin-Ambrosio analysis. Anterior 
chamber depth and anterior chamber angle were within the 
normal range. Dilated funduscopy revealed optically clear 
media throughout the cornea, lens, and vitreous. The retinal 
pigmented epithelial layer showed mottling at the posterior 
pole and diffuse atrophy in the periphery (Figure 1). However, 
neither bone spicule formation nor pigment clumping could 
be observed. Unlike the pale and waxy optic disc associated 
with retinitis pigmentosa (RP), the optic disc in her case was 
slightly pale but had a near normal appearance. The diameter 
of retinal vessels was apparently normal, and vascular attenu-
ation could not be observed. The central foveal spot was 
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enlarged (Figure 1). Diabetic retinopathy was not observed 
during the investigation period.
Fundus autofluorescence imaging presented a dark fovea 
surrounded by a hyperreflective ring, as seen in other heredi-
tary retinal dystrophies [20]. Increased autofluorescence of 
the choroid was detected, most likely due to the atrophy and 
mottling of the RPE in the posterior pole. No typical spot or 
patchy reflectance of lipofuscin could be seen. Optical coher-
ence tomography showed reduced retinal thickness. Outside 
the fovea, the neurosensory retina was composed of only six 
layers, lacking the external limiting membrane, photoreceptor 
outer segment, and photoreceptor inner segment. An optically 
dense discoid remnant of photoreceptors was detected in the 
central fovea. The extent of the disc representing photorecep-
tors in the fovea showed constriction during the investigation 
period, indicating the progressive loss of cone photoreceptors 
(Figure 2).
Electric signals of retinal origin could not be differ-
entiated from background noise with any of the standard 
ERG settings, including the dark-adapted 0.01 ERG (rod 
response), dark-adapted 3.0 ERG (maximal combined rod-
cone response), dark-adapted 3.0 oscillatory potentials, 
light-adapted 3.0 ERG (single-f lash photopic ERG), and 
light-adapted 3.0 flicker ERG (30 Hz flicker) settings (Figure 
Figure 1. Fundus photography. 
Color fundus photos of the posterior 
pole (right eye: A; left eye: B) and 
periphery (right eye: C; left eye: 
D). Pictures represent fine mottling 
of the RPE in the macular area 
and RPE atrophy in the periphery. 
Arrows point to the enlarged fovea 
corresponding to the disc-shaped 
remnant of photoreceptors. Auto-
f luorescent fundus photos (right 
eye: E; left eye: F) show increased 
overall autof luorescence, origi-
nating most likely from the choroid. 
Arrowheads point to the parafoveal 
hyperreflective ring, a character-
istic sign of retinal dystrophies.
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Figure 2. OCT imaging of the 
macula. Results of the OCT exami-
nations in 2009, 2011, and 2014, 
right eye (A, C, E, respectively) and 
left eye (B, D, F, respectively). The 
arrowheads indicate the borders 
of the discoid remnant of cone 
photoreceptors in the central fovea. 
Note the progressive constriction of 
the photoreceptor layer. The retina 
outside this area lacks photorecep-
tors and is composed of only seven 
layers.
Figure 3. Standard full-field elec-
troretinography. A: 1: dark-adapted 
0.01 ERG (rod response) right eye; 
2: dark-adapted 0.01 ERG (rod 
response) left eye; 3: dark-adapted 
3.0 ERG (maximal combined 
rod–cone response), right eye; 4: 
dark-adapted 3.0 ERG (maximal 
combined rod-cone response), left 
eye. B: 1: light-adapted 3.0 ERG 
(single-flash photopic ERG), right 
eye; 2: light-adapted 3.0 ERG 
(single-f lash photopic ERG), left 
eye. C: 1: dark-adapted 3.0 oscilla-
tory potentials, right eye; 2: dark-
adapted 3.0 oscillatory potentials, 
left eye. D: 1: light-adapted 3.0 
flicker ERG (30 Hz flicker), right 
eye; 2: light-adapted 3.0 f licker 
ERG (30 Hz flicker), left eye.
Molecular Vision 2015; 21:124-130 <http://www.molvis.org/molvis/v21/124> © 2015 Molecular Vision 
128
3). Peripapillary nerve–fiber layer thickness showed normal 
values in both eyes.
DISCUSSION
NEUROD1 takes part in the development of the endocrine 
pancreas and neuronal elements, including the retina. Most 
of our knowledge about the function of the protein comes 
from animal experiments. NEUROD1 knockout animals die 
shortly after birth due to severe diabetes. Long-term effects of 
gene knockout on the retina could only be investigated either 
by prolonging survival [6, 8] or restricting the gene knockout 
to the retina [11]. Pennesi et al. [8] investigated the role of 
NEUROD1 in the retina using knockout mice that survived 
until adulthood. The two- to three-month-old homozygous 
null mice showed a reduction in rod- and cone-driven elec-
troretinograms and shortened outer photoreceptor segments. 
The thicknesses of the outer nuclear and the outer plexiform 
layers were reduced, but there were no changes in the inner 
nuclear, inner plexiform, and ganglion cell layers. In addition, 
the 18-month-old NEUROD1 KO retina was totally devoid 
of photoreceptors. Ochocinska et al. [11] used conditional 
KO mice to investigate the role of NEUROD1 in the adult 
retina. The retinal morphology represented a shortened and 
disorganized outer segment and dramatic reduction in rod- 
and cone-driven electroretinograms at two months of age. 
At older ages, photoreceptors were completely absent. Photo-
receptor damage equally affected rods and cones. However, 
for the inner nuclear, inner plexiform, and ganglion cell 
layers, no obvious morphological changes were seen. These 
findings suggest that NEUROD1 plays an important role in 
maintaining functional and structural integrity of the photo-
receptors, and that homozygous null mice progress rapidly to 
the complete loss of photoreceptors.
Homozygous null mutations in the NEUROD1 gene 
were suspected to be lethal in humans [8] until Cabezas et al. 
[18] reported two patients with homozygous loss-of-function 
mutations in the NEUROD1 gene in 2010. Both patients had 
permanent neonatal diabetes and severe neurologic abnor-
malities, including cerebellar hypoplasia, developmental 
delay, and visual and hearing impairment. However, detailed 
ophthalmological phenotypes of patients with homozygous 
NEUROD1 null mutations have not yet been documented. 
Our purpose with the present study was therefore to provide 
a detailed description of the functional and anatomic charac-
teristics attributed to a homozygous NEUROD1 null mutation 
in humans and to compare our findings with those described 
in animal models.
The young female patient reported by Cabezas [18] with 
the homozygous c.427_428delCT NEUROD1 mutation was 
investigated on multiple occasions in a five-year period. The 
patient had diminished night vision from early childhood 
and showed severe visual field constriction with mostly 
preserved central visual acuity. These symptoms are similar 
to those caused by typical retinitis pigmentosa and indicate 
a rod–cone dystrophy pattern. In line with these symptoms, 
optical coherence tomography showed a discoid remnant of 
cone photoreceptors in the fovea and a total lack of photo-
receptors outside the fovea. In this region, the retina was 
totally devoid of photoreceptors. Electroretinography showed 
absent dark- and light-adapted responses. The lack of dark-
adapted ERG responses can be explained by the total lack 
of rod photoreceptors. Undetectable cone responses in the 
light-adapted ERG settings can be explained by the reduction 
in the number of cone photoreceptors and a damaged photo-
receptor function. Despite the severely diminished retinal 
function, the ocular fundus was less compromised than with 
typical retinitis pigmentosa. Although RPE showed mottling 
in the posterior pole, no bone spicules or pigment clumps 
were present. Optic-disc pallor and retinal-vessel attenuation 
were also less prominent than in RP cases. Fundus autofluo-
rescence imaging showed increased fundus autofluorescence 
and a hyperreflective parafoveal ring. This phenomenon has 
been described in cases of retinitis pigmentosa [20-23], rod–
cone dystrophies [24], and other inherited retinal diseases 
[24-26]. Our result is in accordance with the presumption that 
the ring can be a prognostic factor of macular dysfunction 
[20, 22, 27, 28] and corresponds to a transition zone between 
a functional and dysfunctional retina [20, 27-29].
Most of our knowledge on the function of NEUROD1 
comes from animal models. NEUROD1 seems to be neces-
sary for the maintenance of normal photoreceptor structure 
and function. The absence of NEUROD1 leads to severe 
retinal dystrophy [8, 13]. Our study demonstrates the first 
detailed description of an ophthalmological phenotype caused 
by a homozygous NEUROD1 null mutation in humans and 
indicates that it causes severe rod–cone dystrophy. Although 
it resembles retinitis pigmentosa in many aspects, it can be 
clearly distinguished from it. The relatively spared pigmented 
epithelial layer, the normal appearance of the optic disc and 
retinal vessel, and the disc-shaped remnant of cone photo-
receptors in the fovea are characteristic hallmarks of the 
disease, distinguishing it from any other hereditary retinal 
dystrophies. The total lack of rod photoreceptors, sharply 
demarcated from relatively spared foveal photoreceptors, is 
also an unusual phenotype.
Therefore, we believe that this case not only represents 
a novel genotype–phenotype correlation but also delineates 
a novel form of syndromatous hereditary retinal dystrophy, 
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and provides insight into the role of NEUROD1 in retinal 
homeostasis. Moreover, we cannot exclude the possible role of 
the NEUROD1 gene in non-syndromatous retinal dystrophies 
of so-far undetermined genetic origin. The findings of our 
report confirm the observations of knockout animal models. 
To the best of our knowledge, this is the first detailed descrip-
tion of the ophthalmological consequences of a homozygous 
NEUROD1 mutation in humans. Our results are the first to 
show that the loss of NEUROD1 has similar effects on the 
human retina as have been previously shown in animal exper-
iments. Our report can help in diagnosing NEUROD1-related 
retinal dystrophies in the future and provides information on 
disease progression.
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